Structural Formula (Byq00 0000 01)
Byqlovi For Suspension
Product Images NDC 82667-021
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Byqlovi (NDC 82667-021). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Harrow Eye, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Byq00 0000 02)
Figure 2 (Byq00 0000 03)
Principal Display Panel (3.5 mL Carton Label)
This text provides information about BYQLOVI, an ophthalmic suspension for topical application in the eye. It contains 0.5 mg/mL of clobetasol propionate and comes in a 3.5mL sterile container. The suspension includes various inactive ingredients and a preservative. It is distributed by Harrow Eye, LLC™ in Nashville, TN, USA. The recommended storage temperature is between 16°C to 25°C (69°F to 77°F), and it should not be frozen. Users are advised not to use the product if the tamper-evident overcap is not intact.*
Principal Display Panel (3.5 mL Bottle Label)
This product contains clobetasol propionate 0.5 mg/mL (0.05%) in a 35mL ophthalmic suspension. It is for topical application only and should be stored upright at 15°C to 25°C. Distributed by Harrow Eye, LLC™ in the USA. Do not use if tamper-evident overcap is not intact. NDC: 82667-021-05.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
